Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05893420 · ClinicalTrials.gov registry record · NA
A Rapid Diagnostic of Risk in Hospitalized Patients Using Machine Learning
A NA study of COVID-19 and Sepsis, sponsored by AgileMD.
- Active
- Registry status
- NA
- Development phase
- 30,000
- Enrollment target
- 3
- Study locations
NCT05893420 is a NA study of COVID-19 and Sepsis that is active but no longer recruiting, run by AgileMD. The registered enrollment target is 30,000 participants, below the 55,067-participant average among 203 other COVID-19 trials with a reported enrollment target (46% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT05893420, a NA study of COVID-19 and Sepsis, is active but no longer recruiting, sponsored by AgileMD.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 30,000 participants
- Enrollment target
- 3
- Study locations
Study Summary
In this study, the investigators will deploy a software-based clinical decision support tool (eCARTv5) into the electronic health record (EHR) workflow of multiple hospital wards. eCART's algorithm is designed to analyze real-time EHR data, such as vitals and laboratory results, to identify which patients are at increased risk for clinical deterioration. The algorithm specifically predicts imminent death or the need for intensive care unit (ICU) transfer. Within the eCART interface, clinical teams are then directed toward standardized guidance to determine next steps in care for elevated-risk patients. The investigators hypothesize that implementing such a tool will be associated with a decrease in ventilator utilization, length of stay, and mortality for high-risk hospitalized adults.
Conditions Studied
Interventions
- OTHER Standard of care control
- DEVICE eCARTv5 clinical deterioration monitoring
Study Locations (3)
Connecticut
- Yale New Haven Health System - New Haven
Florida
- BayCare Health System - Clearwater
Wisconsin
- University of Wisconsin Health - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30,000 participants |
| Start Date | 2024-12-31 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05893420
The ClinicalTrials.gov registry entry for NCT05893420 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 30,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 55,067-participant average among 203 other COVID-19 trials with a reported enrollment target (46% lower). The listed sponsor is AgileMD, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 7 conditions, with COVID-19 appearing as the primary indexed condition, and to 2 interventions - of which Standard of care control is the first listed.
NCT05893420 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Connecticut, Florida, Wisconsin.
Frequently Asked Questions
What is clinical trial NCT05893420 about?
NCT05893420 is a clinical study titled "A Rapid Diagnostic of Risk in Hospitalized Patients Using Machine Learning". In this study, the investigators will deploy a software-based clinical decision support tool (eCARTv5) into the electronic health record (EHR) workflow of multiple hospital wards. eCART's algorithm is designed to analyze real-time EHR data, such as vitals and laboratory results, to identify which pa...
What is the current status of trial NCT05893420?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 30,000 participants. The study started on 2024-12-31. Estimated completion is 2026-12-31.
What conditions does trial NCT05893420 study?
This clinical trial studies the following conditions: COVID-19, Sepsis, Respiratory Failure, Cardiac Arrest, Hemodynamic Instability.
What interventions are being tested in trial NCT05893420?
The interventions under investigation include: Standard of care control (OTHER), eCARTv5 clinical deterioration monitoring (DEVICE).
Who is sponsoring clinical trial NCT05893420?
This trial is sponsored by AgileMD, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05893420 being conducted?
This trial has 3 study locations across Connecticut, Florida, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COVID-19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19
RECRUITING · NA
-
Music Mindfulness Study 2a.
RECRUITING · NA
-
Percutaneous Electrical Nerve Field Stimulation (PENFS) in Patients With Post Concussion Syndrome (PCS)
RECRUITING · NA
-
Impact of Aerosol Box Use During Cardiopulmonary Arrest: A Multicenter Study
RECRUITING · NA
-
Evaluating the Impact of Social Music
RECRUITING · NA
-
The SINCERE Intervention to Address COVID-19 Health Disparities
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.